X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (44) 44
female (33) 33
male (26) 26
oncology (26) 26
middle aged (25) 25
adult (23) 23
index medicus (23) 23
aged (20) 20
immunohistochemistry (18) 18
cancer (15) 15
pathology (13) 13
tumors (11) 11
aged, 80 and over (10) 10
article (10) 10
expression (9) 9
metastasis (8) 8
prognosis (8) 8
retrospective studies (8) 8
neuroendocrine tumors (7) 7
apoptosis (6) 6
neoplasm metastasis (6) 6
pancreatic neoplasms - pathology (6) 6
analysis (5) 5
gene expression (5) 5
genetic aspects (5) 5
medicine (5) 5
medicine, research & experimental (5) 5
research (5) 5
therapy (5) 5
vegfr2 (5) 5
young adult (5) 5
adolescent (4) 4
angiogenesis (4) 4
biomarkers (4) 4
breast cancer (4) 4
breast neoplasms - genetics (4) 4
breast neoplasms - pathology (4) 4
breast-cancer (4) 4
chemotherapy (4) 4
gene (4) 4
gene expression profiling - methods (4) 4
genes (4) 4
lung (4) 4
medicine & public health (4) 4
neoplasm staging (4) 4
neoplasms (4) 4
neuroendocrine tumor (4) 4
proto-oncogene proteins c-akt - metabolism (4) 4
survival (4) 4
treatment outcome (4) 4
vascular endothelial growth factor (4) 4
adenocarcinoma (3) 3
adenoma - pathology (3) 3
animals (3) 3
antineoplastic agents - adverse effects (3) 3
antineoplastic agents - therapeutic use (3) 3
biomarkers, tumor - analysis (3) 3
biomarkers, tumor - metabolism (3) 3
biopsy (3) 3
cancer invasiveness (3) 3
carcinoid (3) 3
carcinoma (3) 3
carcinomas (3) 3
cell line, tumor (3) 3
cell-death (3) 3
classification (3) 3
colorectal carcinoma (3) 3
colorectal neoplasms - pathology (3) 3
development and progression (3) 3
diagnosis (3) 3
disease (3) 3
endothelial growth-factor (3) 3
gastroenterology & hepatology (3) 3
gene expression regulation, neoplastic (3) 3
glutathione-s-transferase (3) 3
identification (3) 3
immunotherapy (3) 3
liver (3) 3
liver neoplasms - secondary (3) 3
mice (3) 3
neoplasms - drug therapy (3) 3
neuroendocrine carcinoma (3) 3
neuroendocrine tumors - pathology (3) 3
oligonucleotide array sequence analysis (3) 3
overexpression (3) 3
pancreas (3) 3
pancreatic neoplasms - metabolism (3) 3
pancreatic neuroendocrine tumor (3) 3
patients (3) 3
proteins (3) 3
radiography (3) 3
reproducibility of results (3) 3
reverse transcriptase polymerase chain reaction (3) 3
review (3) 3
risk factors (3) 3
skin and connective tissue diseases (3) 3
tissue array analysis (3) 3
tissues (3) 3
tomography, x-ray computed (3) 3
toxicity (3) 3
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2016, ISBN 9781493934263
This comprehensive subspecialty reference book on NeuroEndocrine Tumor (NET) pathology brings together the diagnostic and clinical expertise of an outstanding... 
Medicine | Pathology | Oncology
Web Resource
2016, ISBN 9781493934263
This comprehensive subspecialty reference book on NeuroEndocrine Tumor (NET) pathology brings together the diagnostic and clinical expertise of an outstanding... 
Medicine | Pathology | Oncology
Web Resource
01/2016, 1st ed. 2016, ISBN 1493934244, 536
This comprehensive subspecialty reference book on NeuroEndocrine Tumor (NET) pathology brings together the diagnostic and clinical expertise of an outstanding... 
Clinical & internal medicine | Neuroendocrine tumors | Pathology | Medicine & Public Health | Oncology
eBook
CANCER GENOMICS & PROTEOMICS, ISSN 1109-6535, 09/2019, Volume 16, Issue 5, pp. 309 - 318
Journal Article
Cancer, ISSN 0008-543X, 01/2011, Volume 117, Issue 2, pp. 268 - 275
Journal Article
Breast Cancer Research and Treatment, ISSN 0167-6806, 1/2010, Volume 119, Issue 2, pp. 335 - 346
Historical data have indicated the potential for the histologically-normal breast to harbor pre-malignant changes at the molecular level. We postulated that a... 
Proliferative biology | Oncology | Medicine & Public Health | Malignancy risk | Pre malignant changes | CANCER SURVIVAL | PROFILES | IDENTIFICATION | ADJACENT | HETEROZYGOSITY | MOLECULAR PORTRAITS | LOCAL RECURRENCE | EPITHELIUM | ONCOLOGY | CARCINOMAS | EXPRESSION SIGNATURE | DNA microarrays | Genes | Genetic research | Development and progression | Genetic aspects | Gene expression | Health aspects | Cancer
Journal Article
Cancer Research, ISSN 0008-5472, 08/2015, Volume 75, Issue 15 Supplement, pp. 4175 - 4175
Journal Article
PLoS ONE, ISSN 1932-6203, 11/2013, Volume 8, Issue 11, p. e80292
A robust immunohistochemical (IHC) assay for VEGFR2 was developed to investigate its utility for patient tailoring in clinical trials. The sensitivity,... 
BREAST-CANCER | TARGETED THERAPY | FACTOR VEGF | MURINE MODEL | COLORECTAL-CANCER | MULTIDISCIPLINARY SCIENCES | PANCREATIC-CANCER | TISSUE MICROARRAYS | CONTAINING REGIMENS | OVARIAN-CARCINOMA | IN-SITU | Prognosis | Carcinoma, Squamous Cell - metabolism | Humans | Lung Neoplasms - metabolism | Middle Aged | Kaplan-Meier Estimate | Vascular Endothelial Growth Factor Receptor-2 - metabolism | Male | Aged, 80 and over | Cell Line, Tumor | Female | Aged | In Vitro Techniques | Medical research | Squamous cell carcinoma | Analysis | Medicine, Experimental | Diagnosis | Lung cancer, Non-small cell | Mass spectrometry | Vascular endothelial growth factor | Tumors | Cancer | Lung cancer | Immunoblotting | Assaying | Cancer therapies | Blood | Ovarian cancer | Proteins | Angiogenesis | Cell growth | Quantitative analysis | Evaluation | Immunoglobulins | Melanoma | Blood vessels | Mass spectroscopy | Lung carcinoma | Survival | Patients | Chemotherapy | Statistical models | Antiangiogenics | Ligands | Laboratories | Clinical trials | Kinases | Tissues | Ethics | Antiangiogenic agents | Larynx | Mathematical models | Cervical carcinoma | Vascular endothelial growth factor receptor 2 | Statistical analysis | Cell survival | Small cell lung carcinoma | Review boards | Tumor cells | Cloning | Non-small cell lung carcinoma | siRNA | Cervix | Human rights | Medical prognosis | Immunoreactivity | Quantitative evaluation
Journal Article
Cancer Discovery, ISSN 2159-8274, 07/2016, Volume 6, Issue 7, pp. 740 - 753
We evaluated the safety, pharmacokinetic profile, pharmacodynamic effects, and antitumor activity of abemaciclib, an orally bioavailable inhibitor of... 
KINASE 4/6 INHIBITOR | CYCLIN-DEPENDENT KINASES | DOSE-ESCALATION | PALBOCICLIB | ONCOLOGY | PROLIFERATION | OVARIAN-CANCER | ANTITUMOR-ACTIVITY | COMBINATION | PD 0332991 | PHASE-I | Cyclin-Dependent Kinase 6 - antagonists & inhibitors | Lung Neoplasms - drug therapy | Humans | Aminopyridines - pharmacokinetics | Aminopyridines - adverse effects | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Tomography, X-Ray Computed | Antineoplastic Agents - therapeutic use | Carcinoma, Non-Small-Cell Lung - diagnosis | Neoplasms - diagnosis | Antineoplastic Agents - administration & dosage | Molecular Targeted Therapy | Neoplasm Metastasis | Aminopyridines - therapeutic use | Benzimidazoles - administration & dosage | Antineoplastic Agents - adverse effects | Female | Antineoplastic Agents - pharmacokinetics | Benzimidazoles - adverse effects | Cyclin-Dependent Kinase 4 - antagonists & inhibitors | Benzimidazoles - therapeutic use | Disease Models, Animal | Aminopyridines - administration & dosage | Benzimidazoles - pharmacokinetics | Neoplasms - mortality | Treatment Outcome | Breast Neoplasms - drug therapy | Neoplasms - drug therapy | Xenograft Model Antitumor Assays | Animals | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - diagnosis | Mice | Carcinoma, Non-Small-Cell Lung - drug therapy | Drug Monitoring | Lung Neoplasms - diagnosis | Neoplasm Staging | Index Medicus
Journal Article
Human Pathology, ISSN 0046-8177, 2009, Volume 40, Issue 3, pp. 341 - 348
Journal Article
Cancer Research, ISSN 0008-5472, 08/2015, Volume 75, Issue 15 Supplement, pp. 4161 - 4161
Journal Article
Investigational New Drugs, ISSN 0167-6997, 8/2017, Volume 35, Issue 4, pp. 442 - 450
Purpose Macrophage-stimulating 1-receptor (RON) is expressed on macrophages, epithelial cells, and a variety of tumors. Narnatumab (IMC-RON8; LY3012219) is a... 
RON | Medicine & Public Health | Macrophage-stimulating protein receptor | Oncology | Narnatumab | Solid tumors | Phase 1 | Pharmacology/Toxicology | IMC-RON8 | LUNG | RENAL ONCOCYTOMA | TYROSINE KINASE RON | Solid | CELL CARCINOMA | CROSS-TALK | OVEREXPRESSION | tumors | COEXPRESSION | ONCOLOGY | PHARMACOLOGY & PHARMACY | MACROPHAGE-STIMULATING PROTEIN | MET | EXPRESSION | Neoplasms - metabolism | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal - therapeutic use | Male | Antineoplastic Agents - therapeutic use | Young Adult | Neoplasms - blood | Antineoplastic Agents - adverse effects | Aged, 80 and over | Receptor Protein-Tyrosine Kinases - antagonists & inhibitors | Adult | Female | Antineoplastic Agents - pharmacokinetics | Antineoplastic Agents - pharmacology | Cytokines - blood | Antibodies, Monoclonal - pharmacology | Antibodies, Monoclonal - pharmacokinetics | Treatment Outcome | Neoplasms - drug therapy | Administration, Intravenous | Maximum Tolerated Dose | Aged | Neoplasms - pathology | Complications and side effects | Care and treatment | Analysis | Monoclonal antibodies | Dosage and administration | Research | Pharmacokinetics | Tumors | Alternative splicing | Animal models | Accessibility | Toxicity | Epithelial cells | mRNA | Macrophages | Anticancer properties | Vomiting | Hypokalemia | Appetite | Pharmacodynamics | Hyponatremia | Diarrhea | Fatigue | Radioactive half-life | Nausea | Pharmacology | Macrophage-stimulating protein | Patients | Ron protein | Studies | Neutralizing | Antitumor activity | MSP protein | Cytoplasm | Index Medicus
Journal Article
Cancer Research, ISSN 0008-5472, 08/2015, Volume 75, Issue 15 Supplement, pp. 4157 - 4157
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.